Agena Bioscience^®新闻报道

Agena和DaRui Biotechnology宣布中国药监局批准MassARRAY^®诊断技术在中国使用 更多

加州圣迭戈和中国广州，2018年10月24日（星期三） - Agena Bioscience (Agena)和DaRui Biotechnolog (DaRui)……

Agena Bioscience宣布与PerkinElmer开展合作 更多

Combining LabChip^® GX Touch Nucleic Acid Analyzer and MassARRAY^® for Optimized Liquid Biopsy WorkflowSan...

Agena宣布MassARRAY^®技术获选加入CANCER-ID联盟 更多

加州圣迭戈，2018年7月24日 - 分子测试解决方案的全球性提供商Agena Bioscience今天宣布……

Agena Announces MassARRAY^® Commercial Partnership Agreement With Dian For China Clinical Laboratory Market More

San Diego, CA, July 10, 2018 – Agena Bioscience announced today that it has entered into a commercial partnership agreement...

GenomeWeb 360Dx: Agena Looks to China for Global Expansion of the MassARRAY Platform More

New York, NY (360DX), June 6, 2018 –  For Agena Bioscience CEO Peter Dansky, expanding a diagnostics company means going...

Agena and Simceredx Announce Strategic Partnership to Develop and Commercialize Companion Diagnostics in China More

San Diego, CA, and Nanjing, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the...

Agena Bioscience’s Liquid Biopsy Technology Awarded Horizon 2020 Grant by European Union More

San Diego, CA, November 30, 2017 – Agena Bioscience, a global provider of molecular genetic solutions, today announced...

Agena Bioscience Bolsters MassARRAY Insights™ Reporting Network by Adding N-of-One More

The collaboration will focus on results interpretation for cancer genomics.San Diego, CA, October 5, 2017– Agena Bioscience,...

Highly Sensitive Assessment Of Common Somatic Mutations In Pulmonary Non-Small Cell Carcinoma With the MassARRAY^® System More

San Diego, CA, September 27, 2017 – Agena Bioscience today announced a comparative study published in PLOS ONE highlighting...

Agena Bioscience Announces Molecular Health As The First Interpretation Software Provider For MassARRAY Insights™ More

MassARRAY Insights providers will aid in results interpretationSan Diego, CA, September 19, 2017– Agena Bioscience, a...

Intermountain Precision Genomics Launches Antidepressant PGx Panels Developed on Agena MassARRAY^® More

NEW YORK, Sept 15, 2017 – Intermountain Precision Genomics’ RxMatch Antidepressant Panel, announced last week, is the...

MassARRAY^® System Selected for Illinois State Cystic Fibrosis Screening of Newborns More

San Diego, CA, August 2, 2017– Agena Bioscience has entered into a 3-year agreement with the Illinois Department of Public...